TMS vs Ketamine Therapy: Comparing Two Brain Treatments for Depression

You have tried antidepressants. Maybe two, maybe five. Your depression persists, and now you are researching treatments that go beyond the pill bottle. Two names keep coming up: TMS (Transcranial Magnetic Stimulation) and ketamine therapy.

Both are legitimate, evidence-backed treatments for depression, including treatment-resistant depression (TRD). But they work in completely different ways, on completely different timelines, with different cost structures and different trade-offs. Choosing between them (or deciding to try both) requires understanding those differences clearly.

This guide puts TMS and ketamine side by side across every factor that matters: mechanism, efficacy, speed, durability, side effects, cost, insurance, and candidacy.

How They Work: Two Completely Different Mechanisms

TMS: Magnetic Brain Stimulation

TMS delivers focused magnetic pulses through the skull to the left dorsolateral prefrontal cortex (DLPFC), a brain region consistently underactive in depression. These pulses generate small electrical currents in targeted neurons, gradually increasing excitability and restoring healthier communication between the prefrontal cortex and deeper emotional-processing regions like the subgenual cingulate and amygdala.

The mechanism is neuromodulatory: TMS reshapes circuit function over time through repeated stimulation, promoting long-term neuroplastic changes. Think of it as physical therapy for a brain network that is stuck.

Ketamine: Rapid Neurochemical Reset

Ketamine works primarily by blocking NMDA glutamate receptors, which triggers a cascade of downstream effects: a surge in brain-derived neurotrophic factor (BDNF), rapid formation of new synaptic connections, and a shift in neural network activity, particularly in the default mode network, which is overactive in depression.

The mechanism is neurochemical and synaptogenic: ketamine rapidly creates new synaptic connections and briefly disrupts rigid thought patterns (which is partly why it produces dissociative effects). It works fast but the effects are biochemically time-limited without repeated dosing.

Head-to-Head Comparison: TMS vs Ketamine

Here is the full comparison across every factor that matters when choosing between these treatments:

Speed vs Durability: The Core Trade-Off

The single most important distinction between TMS and ketamine boils down to this: ketamine is fast but fades. TMS is slow but sticks.

Ketamine can produce noticeable mood improvement within hours of a single infusion. For someone in acute crisis, especially someone with active suicidal ideation, that speed can be lifesaving. But the effect of any individual infusion typically wears off within 2-4 weeks, which is why ongoing booster infusions are necessary.

TMS, by contrast, takes 2-4 weeks of daily sessions before most patients notice a clear shift. The improvement is gradual, sometimes hard to notice until you look back at where you started. But once a full course is completed, the benefits tend to persist for 12 or more months without any ongoing treatment, because TMS produces lasting changes in circuit function rather than a temporary neurochemical shift.

Who Is a Better Candidate for Each?

TMS may be the better fit if you:

• Have moderate-to-severe depression that has not responded to 1-2 medications
• Want a treatment with minimal systemic side effects
• Prefer not to experience dissociative or altered states
• Can commit to a 6-week daily schedule (or 5-day accelerated protocol)
• Want insurance to cover a significant portion of the cost
• Are looking for a durable result without indefinite ongoing treatment

Ketamine may be the better fit if you:

• Need rapid relief (especially if experiencing suicidal ideation)
• Have severe, acute depression and cannot wait 4-6 weeks for effect
• Have failed multiple treatments and want to try a fundamentally different mechanism
• Are comfortable with the dissociative experience during sessions
• Can budget for ongoing booster costs (or have Spravato coverage)
• Have comorbid PTSD or chronic pain (ketamine may address both)

Can You Do Both? Combining TMS and Ketamine

Yes, and some treatment-resistant patients benefit most from a combined approach. There are a few strategies clinicians use:

• Sequential: Start with ketamine to get rapid stabilization, then transition to TMS for long-term circuit remodeling. This is especially useful when immediate relief is needed but the goal is durable remission without indefinite booster infusions.
• Concurrent: Some clinics offer ketamine and TMS simultaneously or within the same treatment week. Early research suggests the neuroplasticity-boosting effects of ketamine may actually enhance TMS’s ability to reshape circuits, you are essentially doing brain stimulation while the brain is primed to rewire.
• TMS first, ketamine as rescue: Complete a full TMS course, and if the response is partial, add ketamine to address remaining symptoms or use it as a rescue intervention for breakthrough depressive episodes.

Combining treatments is still an evolving area of research, and insurance is unlikely to cover both simultaneously. But the biological rationale is sound, and many treatment-resistant patients find that one alone is not enough.

Cost and Insurance Reality Check

Cost is often the deciding factor, so let’s be transparent:

TMS has a higher upfront cost ($6,000-$12,000 for a full course) but is now widely covered by insurance for MDD after medication failure. With coverage, many patients pay only specialist copays, making the effective out-of-pocket cost quite manageable. And because TMS effects are durable, you are often done paying after the initial course.

Ketamine (IV) has a lower initial cost ($2,400-$4,800 for a 6-infusion course) but is almost never covered by insurance and requires ongoing booster infusions ($400-$800/month). Over a year, the total cost of IV ketamine often exceeds TMS.

Spravato (esketamine) is increasingly covered by insurance through prior authorization, but requires in-office administration with 2-hour monitoring, which creates logistical burden. Copays and coverage vary widely.

Frequently Asked Questions

Which works better for treatment-resistant depression, TMS or ketamine?

The response rates are roughly comparable (56-60% for TMS, 60-70% for ketamine), but “better” depends on your priorities. Ketamine works faster but requires ongoing treatment. TMS takes longer but produces more durable results. For many TRD patients, both are worth trying, either sequentially or in combination.

Can I switch from one to the other if the first doesn’t work?

Absolutely. Failing to respond to TMS does not predict failure with ketamine, and vice versa, because they work through different mechanisms. Many patients try one, get a partial response, and add or switch to the other.

Is one safer than the other?

TMS has a milder side-effect profile overall, no systemic effects, no altered consciousness, no abuse potential. Ketamine carries dissociative effects during treatment, potential blood pressure changes, and a small risk of bladder issues with chronic high-dose use. Both are considered safe when administered properly, but TMS has fewer medical monitoring requirements.

What if I have both depression and anxiety?

Both treatments can help with comorbid anxiety. TMS has FDA clearance for “anxious depression” specifically, and many patients report anxiety improvement alongside depression relief. Ketamine also tends to reduce anxiety symptoms, though the dissociative experience during treatment can temporarily increase anxiety in some people. Discuss your specific anxiety profile with your provider.

Related Reading

This article connects two of our thorough treatment guides. Explore both for deeper information:

TMS Therapy: The Complete Guide →

Ketamine Therapy: The Complete Guide →